Ferric Pyrophosphate (Iron)

Evidence Level
Moderate
10 Clinical Trials
6 Documented Benefits
3/5 Evidence Score

Ferric pyrophosphate is an iron salt that does not dissolve in water. Because it barely changes the taste or color of food, it is used to fortify cereals, rice and salt, and it is the iron in several encapsulated supplements. The trade-off is absorption: women absorbed a quarter to a third as much iron from the standard powder as from ferrous sulfate. Very fine, dispersible versions closed much of that gap in some meals, but not in rice. In controlled trials in children, rice or salt fortified with the micronized form raised iron stores. In two short trials in pregnant women with low iron, 27 to 30 mg a day raised hemoglobin as much as or more than ferrous iron salts, with fewer stomach complaints; the tablet marketer paid the costs of one, and the other added alpha-lactalbumin. Take iron only if a blood test shows you need it.

Studied Dose Supplements: 27 to 30 mg elemental iron/day for 4 weeks in pregnant women with low iron. Fortified foods: about 18 to 20 mg iron/day from salt or rice for 7 to 10 months in children. US adult upper limit: 45 mg/day of iron.
Active Compound Ferric pyrophosphate (iron(III) pyrophosphate), a tan or yellowish white, water-insoluble iron salt; sold as standard powder or as micronized, dispersible, emulsified or encapsulated forms.

Benefits

Iron levels in pregnant women with low iron stores

In a 4-week open-label trial of 111 pregnant women with low iron, a 27 mg iron tablet of emulsified ferric pyrophosphate (with vitamin C, B12, folic acid and glycine) raised hemoglobin by 2.63 g/dL, matching 100 mg of iron as ferrous ascorbate; the tablet's marketer paid the costs. In a 50-woman double-blind trial, 30 mg with alpha-lactalbumin raised hemoglobin more than 80 mg of ferrous gluconate, while ferritin gains did not differ.

Fewer stomach complaints than ferrous iron salts

In the 111-woman pregnancy trial, nausea, dark stools and acidity were reported only on ferrous ascorbate (11.1% had side effects), not on ferric pyrophosphate. In a 50-woman double-blind trial, 24% had side effects on ferrous gluconate against none of note on 30 mg micronized ferric pyrophosphate taken with alpha-lactalbumin. The first trial gave far less iron in the ferric pyrophosphate arm.

Raises iron stores when added to staple foods

In double-blind trials in iron-depleted schoolchildren, rice fortified with micronized ferric pyrophosphate (about 19 to 20 mg iron a day for 7 to 8 months) raised iron stores and cut iron deficiency compared with plain rice. Salt fortified with it raised iron stores in two trials, but hemoglobin rose in only one of them.

Absorption depends on particle size and the food it is in

Standard ferric pyrophosphate (particles about 8.5 micrometers) was absorbed about a third as well as ferrous sulfate in women. A micronized, dispersible form (about 0.3 micrometers, with emulsifiers) was absorbed about as well as ferrous sulfate from a cereal and a yogurt drink in two 10-woman isotope studies. In a 26-woman study of another micronized form, it reached 62% of ferrous sulfate in a cereal but 15 to 24% in rice meals.

Iron and ferritin levels in adults with low iron

In an observational study of 119 adults with iron deficiency taking micronized, emulsified ferric pyrophosphate for 3 months, iron rose in 39 of 63 women with repeat tests and ferritin in 38 of 66 patients, and 83% rated the product good or very good. A 60-person single-arm study also reported rising hemoglobin and ferritin. Neither study had a control group.

Little effect on the taste or color of fortified foods

This is the main reason food makers use it. Rice fortified with micronized ferric pyrophosphate could not be told apart from natural rice in sensory tests, cooked or uncooked, and dual-fortified salt kept the same color as iodized salt after 6 months of storage. The FDA lists ferric pyrophosphate as generally recognized as safe for use as a nutrient.

Mechanism of action

1

Insoluble iron that must dissolve before it is absorbed

Ferric pyrophosphate does not dissolve in water, so little of it is freed in the gut, which is why absorption from the standard powder is low. Grinding it into much smaller particles and keeping them suspended with emulsifiers or a coating gives more surface to dissolve, which is the idea behind micronized and encapsulated forms.

2

Low iron stores raise its absorption less than for ferrous sulfate

Soluble salts such as ferrous sulfate are absorbed better when iron stores are low. In 49 young women, ferritin strongly predicted absorption from ferrous sulfate but not from ferric pyrophosphate. Yet in 15 women given a micronized, dispersible form in apple juice, absorption rose as ferritin fell, much as for ferrous sulfate. In child fortification trials, low starting iron predicted a larger gain with both, more so with ferrous sulfate.

3

Vitamin C helps, but less than with ferrous sulfate

Adding vitamin C to a fortified cereal meal raised absorption from ferric pyrophosphate about 2.6-fold, against about 3.7-fold for ferrous sulfate. In a second study, vitamin C took micronized ferric pyrophosphate from 2.0% to 5.8% absorbed and ferrous sulfate from 3.2% to 14.8%.

Clinical trials

1
Micronized Dispersible Ferric Pyrophosphate vs Ferrous Sulfate: Two Isotope Absorption Studies
PubMed

Two stable-isotope absorption studies in adult women comparing micronized, dispersible ferric pyrophosphate (SunActive Fe, average particle size 0.3 micrometers, with emulsifiers) with ferrous sulfate, each at 5 mg iron per test meal; two co-authors were Taiyo Kagaku staff (Fidler et al. 2004, Br J Nutr)

20 adult volunteers, 10 per study, fed an infant cereal or a yogurt drink (see design).

Absorption did not differ significantly: 3.4% vs 4.1% from the cereal (P = 0.24) and 3.9% vs 4.2% from the yogurt drink (P = 0.72). These were single test meals measuring absorption, not changes in body stores.

2
Standard Ferric Pyrophosphate, Particle Size and Vitamin C: Isotope Absorption Studies
PubMed

Three stable-isotope studies in adult women of ferric pyrophosphate in an iron-fortified infant cereal (5 mg iron per meal), with ferrous sulfate as the reference (Fidler et al. 2004, Int J Vitam Nutr Res)

Adult volunteers, 9 to 10 per study (see design).

Absorption from ferric pyrophosphate (particles about 8.5 micrometers) was 0.9% against 2.6% for ferrous sulfate without vitamin C (36% relative bioavailability) and 2.3% against 9.7% with vitamin C (23%). Smaller particles of 6.7 micrometers did not absorb significantly better than 12.5 micrometers (52% vs 42% relative bioavailability).

3
Body Stores Shape Absorption from Ferric Pyrophosphate vs Ferrous Sulfate
PubMed

Stable-isotope test meals in young women selected for low or high iron status (plasma ferritin), plus a re-analysis of body iron change in earlier salt fortification trials in children (Zimmermann et al. 2011, Br J Nutr)

49 young adult volunteers (see design); data from 258 children in previous efficacy trials.

Plasma storage levels strongly predicted absorption from ferrous sulfate (P < 0.0001) but not from ferric pyrophosphate. In the child trials, low starting body stores predicted a bigger gain with both compounds, but significantly more so with ferrous sulfate (P < 0.01).

4
Fortified Rice with Micronized Ferric Pyrophosphate in Indian Schoolchildren: Double-Blind RCT
PubMed

Double-blind, randomized, 7-month school lunch trial in Bangalore, India, in iron-depleted children: a rice meal fortified with 20 mg iron as micronized ground ferric pyrophosphate vs an identical unfortified meal; all children dewormed; outcomes were body iron stores, iron deficiency and iron-deficiency anemia (Moretti et al. 2006, Am J Clin Nutr)

184 schoolchildren aged 6 to 13 with depleted stores; 78% deficient and 29% anemic from low stores at baseline.

Body stores rose more in the fortified group (P < 0.05). Among dewormed children, deficiency fell from 78% to 25% with fortified rice and from 79% to 49% in controls, a significant group by time difference. Anemia from low stores fell from 30% to 15% in the fortified group, which was not statistically significant, and stayed near 28% in controls. The fortified rice was indistinguishable from natural rice in sensory tests.

5
Rice Kernels with Micronized Ferric Pyrophosphate in a Midday Meal: Placebo-Controlled RCT
PubMed

Double-blind, randomized, placebo-controlled 8-month feeding trial in India: a school midday meal with rice providing 19 mg iron as micronized ferric pyrophosphate in extruded kernels vs unfortified rice; outcomes included hemoglobin, serum ferritin and iron deficiency (Radhika et al. 2011, Am J Clin Nutr)

140 schoolchildren aged 5 to 11.

Serum storage levels rose by 8.2 mcg/L with fortified rice (P < 0.001) and deficiency fell from 33% to 14%, against 31% to 37% in controls. Hemoglobin rose similarly in both groups (0.99 vs 1.15 g/dL), and anemia prevalence did not differ between groups.

6
Salt Fortified with Iodine and Micronized Ferric Pyrophosphate in Moroccan Children: RCT
PubMed

Randomized, double-blind 10-month trial of salt fortified with iodine and 2 mg iron per gram as micronized ferric pyrophosphate vs iodized salt, in rural northern Morocco; the salt supplied about 18 mg iron a day, with absorption estimated at about 2%; outcomes included hemoglobin, iron status and iron-deficiency anemia (Zimmermann et al. 2004, Am J Clin Nutr)

158 iodine-deficient children aged 6 to 15 with a high rate of anemia.

In the fortified-salt group, mean hemoglobin rose 16 g/L (P < 0.01), body stores rose (P < 0.01), and anemia from low stores fell from 30% to 5% (P < 0.001). Salt color and iodine content did not change over 6 months of storage.

7
Dual-Fortified Salt in Children in Cote d'Ivoire: Body Stores Rose, Hemoglobin Did Not
PubMed

Double-blind 6-month trial in iron-deficient children of salt fortified with iodine and 3 mg iron per gram as micronized ground ferric pyrophosphate vs iodized salt; children dewormed at baseline; outcomes included serum ferritin, transferrin receptor, body iron and hemoglobin (Wegmuller et al. 2006, J Nutr)

123 children aged 5 to 15 with depleted stores in rural Cote d'Ivoire, 55% of whom had malaria.

Serum storage levels, transferrin receptor and body stores improved in the fortified-salt group but not with iodized salt (body stores 4.6 to 5.9 mg/kg vs 5.5 to 5.6 mg/kg). Hemoglobin and anemia prevalence did not change in either group; the authors suggest malaria and other nutrient deficiencies impaired its use.

8
SunActive Fe 27 mg vs Ferrous Ascorbate 100 mg in Pregnant Women with Low Iron: Open-Label RCT
PubMed

Randomized, open-label, active-controlled, multicenter 4-week trial (CTRI/2024/07/070773). One daily SunActive Fe tablet (27 mg iron with vitamin C, vitamin B12, folic acid and glycine) vs one ferrous ascorbate tablet (100 mg iron with folic acid); primary aim was non-inferiority for hemoglobin change. Material and testing costs were paid by Generex Pharmassist, which employed two co-authors; no Taiyo Kagaku authors (Patki et al. 2025, Sci Rep)

111 second-trimester pregnant women in India aged 20 to 35, hemoglobin 9 to 10.5 g/dL and ferritin below 15 mcg/L; 108 completed.

Hemoglobin rose 2.63 vs 2.62 g/dL (between-group P = 0.973), meeting the non-inferiority margin; ferritin, reticulocyte hemoglobin and FACIT-Fatigue scores (14.1% vs 14.2%) also did not differ. Adverse events occurred in 6 of 54 on ferrous ascorbate and none on SunActive Fe (P = 0.028). The arms differed in iron dose and added vitamins, and the trial was open-label and 4 weeks long.

9
Micronized Ferric Pyrophosphate with Alpha-Lactalbumin vs Ferrous Gluconate in Pregnancy: Double-Blind RCT
PubMed

Double-blind, randomized 30-day trial at one center in Rome: one daily tablet of 30 mg micronized dispersible ferric pyrophosphate plus 300 mg alpha-lactalbumin (Emogut Forte) vs one tablet of 80 mg ferrous gluconate; primary outcomes hemoglobin and ferritin; the authors call it a preliminary trial; no specific funding (Laganà et al. 2018, Eur Rev Med Pharmacol Sci)

50 second-trimester pregnant women with iron-deficiency anemia (hemoglobin below 10.5 g/dL); all 50 completed.

Hemoglobin, ferritin and serum iron rose in both groups. At 30 days hemoglobin had risen 16.35% vs 10.68%, a significantly larger rise with ferric pyrophosphate (P < 0.0001), and serum iron also rose more (P = 0.03), but ferritin, a primary outcome, did not differ between groups (P = 0.38). Side effects occurred in 24% on ferrous gluconate, with no significant side effects on ferric pyrophosphate (P = 0.02). The added alpha-lactalbumin means the result cannot be credited to the iron form alone.

10
Micronized Dispersible Ferric Pyrophosphate vs Ferrous Sulfate in Apple Juice: Isotope Absorption Study
PubMed

Stable-isotope comparison in women with relatively low iron stores of SunActive Fe (micronized, dispersible ferric pyrophosphate) and ferrous sulfate added to pure apple juice, measured by red cell isotope incorporation 14 days later; stores assessed as serum ferritin; funding not described in the abstract (Roe et al. 2009, Eur J Nutr)

15 adult volunteers with relatively low body stores (see design).

Absorption from the micronized form was significantly lower than from ferrous sulfate (5.5% vs 9.1%), a relative bioavailability of 0.6. Absorption from both forms was higher in volunteers with lower stores (micronized form r = -0.76, P = 0.01; ferrous sulfate r = -0.81).

Side effects and drug interactions

Common Potential side effects

Stomach and bowel complaints were less common than with ferrous salts in trials, but they still occur: in an observational study, 41 of the 108 users who completed follow-up questionnaires (38%) reported some discomfort over 3 months of micronized, emulsified ferric pyrophosphate.
The US Tolerable Upper Intake Level for iron is 45 mg/day for adults (40 to 45 mg for children and teens). High doses of iron supplements cause digestive effects, and extremely high doses can be fatal.
Take iron only when a blood test shows low iron or a doctor or midwife advises it. People with hereditary hemochromatosis are at risk of taking in too much iron and should use an iron supplement only if their doctor advises it.
US iron supplements in tablet or capsule form must carry this warning: accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep the product out of reach of children, and in case of accidental overdose, call a doctor or poison control center immediately.

Important Drug interactions

Levothyroxine: iron supplements may interact with it; ask your doctor or pharmacist how to time the two.
Levodopa: iron supplements may interact with it; ask your doctor or pharmacist about timing.
Proton pump inhibitors (acid reducers) can reduce iron absorption.
Calcium supplements: take them at a different time from iron, since calcium can interfere with iron absorption.
Vitamin C taken with ferric pyrophosphate raised its absorption in isotope studies, though less than it raised absorption from ferrous sulfate.

Frequently asked questions about Ferric Pyrophosphate (Iron)

How is ferric pyrophosphate different from ferrous sulfate?

Ferrous sulfate dissolves easily and is well absorbed, especially when iron stores are low. Standard ferric pyrophosphate does not dissolve in water, and women absorbed only about a quarter to a third as much iron from it in test meals. Its advantages are a neutral taste and color in foods and, in micronized or encapsulated forms, absorption that comes much closer to ferrous sulfate.

Is it easier on the stomach than other iron?

In two pregnancy trials, fewer women reported nausea, dark stools or other side effects on micronized or emulsified ferric pyrophosphate than on ferrous salts. The open-label trial gave about a quarter of the comparison iron dose in the ferric pyrophosphate group, and the other added alpha-lactalbumin, so part of the difference may come from dose or formula. Some users still report stomach discomfort.

Does it matter which form of ferric pyrophosphate is used?

Yes. Standard powder with larger particles is poorly absorbed, and modest grinding alone did not help much. Very fine particles kept in suspension with emulsifiers performed far better in absorption studies, though results still varied with the food, from close to ferrous sulfate in a cereal to much lower in rice. The studies describe these forms as micronized, dispersible, emulsified or encapsulated.

How much is safe, and who should take it?

The US upper limit for adults is 45 mg of iron a day. Supplement trials used 27 to 30 mg a day. Take iron only if a blood test shows low iron or a doctor or midwife recommends it, keep iron products away from children, and if you have hemochromatosis, use iron only on your doctor's advice.

What is Ferric Pyrophosphate?

Ferric pyrophosphate is an iron salt that does not dissolve in water. Because it barely changes the taste or color of food, it is used to fortify cereals, rice and salt, and it is the iron in several encapsulated supplements.

What is Ferric Pyrophosphate used for?

Ferric Pyrophosphate is researched primarily for Women's Health. In a 4-week open-label trial of 111 pregnant women with low iron, a 27 mg iron tablet of emulsified ferric pyrophosphate (with vitamin C, B12, folic acid and glycine) raised hemoglobin by 2.

Is Ferric Pyrophosphate safe, and does it have side effects?

Side effects and cautions reported for Ferric Pyrophosphate include: Stomach and bowel complaints were less common than with ferrous salts in trials, but they still occur: in an observational study, 41 of the 108 users who completed follow-up questionnaires (38%) reported some discomfort over 3 months of micronized, emulsified ferric pyrophosphate… It may also interact with some medications. Ferric Pyrophosphate is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Ferric Pyrophosphate interact with any medications?

Possible interactions include: Levothyroxine: iron supplements may interact with it; ask your doctor or pharmacist how to time the two. Levodopa: iron supplements may interact with it; ask your doctor or pharmacist about timing. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Ferric Pyrophosphate?

NutraSmarts rates the evidence for Ferric Pyrophosphate as Moderate (3 out of 5). It is backed by 10 study summaries and 16 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(16 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Patki A, Jyothi GS, Thobbi V, Srivastav A, Ganu G, Shah AS. Efficacy and safety of emulsified microsomal ferric pyrophosphate vs. Ferrous Ascorbate in pregnancy with iron-deficiency anemia- a randomized, comparative study. Sci Rep. 2025;15(1):39671. doi: 10.1038/s41598-025-23353-9.PubMedUsed to support: Randomized, open-label, multicenter 4-week trial (CTRI/2024/07/070773) in 111 second-trimester pregnant women in India with hemoglobin 9 to 10.5 g/dL and ferritin below 15 mcg/L (108 completed). One SunActive Fe tablet a day (27 mg iron plus 50 mg vitamin C, 0.75 mcg vitamin B12, 250 mcg folic acid and 10 mg glycine) raised hemoglobin by 2.63 g/dL, against 2.62 g/dL on ferrous ascorbate (100 mg iron with 1.5 mg folic acid); the prespecified non-inferiority margin was met, and ferritin, reticulocyte hemoglobin and FACIT-Fatigue scores (14.1% vs 14.2%) did not differ between groups. Adverse events (nausea, hyperacidity, dark stools) occurred in 6 of 54 women on ferrous ascorbate and none on SunActive Fe (P = 0.028). Material and testing costs were paid by Generex Pharmassist, which employed two co-authors; no Taiyo Kagaku staff were authors.
  2. Laganà AS, Costabile L, Filati P, Noventa M, Vitagliano A, D'Anna R. Effects of micronised dispersible ferric pyrophosphate combined with alpha-lactalbumin in pregnant women affected by iron deficiency anemia: results from a prospective, double-blind, randomized controlled trial. Eur Rev Med Pharmacol Sci. 2018;22(11):3602-3608. doi: 10.26355/eurrev_201806_15187.PubMedUsed to support: Double-blind randomized 30-day trial in 50 second-trimester pregnant women with iron-deficiency anemia: one daily tablet of 30 mg micronized dispersible ferric pyrophosphate plus 300 mg alpha-lactalbumin vs 80 mg ferrous gluconate. Hemoglobin, ferritin and serum iron improved in both groups; at 30 days the hemoglobin rise was significantly larger with ferric pyrophosphate (16.35% vs 10.68%, P < 0.0001) and serum iron rose more (P = 0.03), but ferritin, a primary outcome, did not differ (P = 0.38). Side effects occurred in 24% on ferrous gluconate; the ferric pyrophosphate group showed no significant side effects (P = 0.02). No specific funding.
  3. Fidler MC, Walczyk T, Davidsson L, Zeder C, Sakaguchi N, Juneja LR, Hurrell RF. A micronised, dispersible ferric pyrophosphate with high relative bioavailability in man. Br J Nutr. 2004;91(1):107-12. doi: 10.1079/bjn20041018.PubMedUsed to support: Two stable-isotope studies in 20 women: micronized, dispersible ferric pyrophosphate (SunActive Fe, about 0.3 micrometer particles with emulsifiers) was absorbed about as well as ferrous sulfate from an infant cereal (3.4% vs 4.1%) and a yogurt drink (3.9% vs 4.2%). Describes ferric pyrophosphate as water-insoluble and normally poorly absorbed. Two co-authors were Taiyo Kagaku staff.
  4. Fidler MC, Davidsson L, Zeder C, Walczyk T, Marti I, Hurrell RF. Effect of ascorbic acid and particle size on iron absorption from ferric pyrophosphate in adult women. Int J Vitam Nutr Res. 2004;74(4):294-300. doi: 10.1024/0300-9831.74.4.294.PubMedUsed to support: Stable-isotope studies in 9 to 10 women each: standard ferric pyrophosphate in infant cereal had 36% of ferrous sulfate's absorption without vitamin C and 23% with it; vitamin C raised its absorption 2.6-fold vs 3.7-fold for ferrous sulfate; particles of 6.7 micrometers were not significantly better absorbed than 12.5 micrometers.
  5. Moretti D, Zimmermann MB, Wegmüller R, Walczyk T, Zeder C, Hurrell RF. Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans. Am J Clin Nutr. 2006;83(3):632-8. doi: 10.1093/ajcn.83.3.632.PubMedUsed to support: Crossover isotope study in 26 young women: relative bioavailability of micronized dispersible ferric pyrophosphate vs ferrous sulfate was 62% in a wheat-milk cereal, 39% with vitamin C, 15% added to a rice meal and 24% in extruded rice grains; iron status strongly predicted relative bioavailability.
  6. Zimmermann MB, Biebinger R, Egli I, Zeder C, Hurrell RF. Iron deficiency up-regulates iron absorption from ferrous sulphate but not ferric pyrophosphate and consequently food fortification with ferrous sulphate has relatively greater efficacy in iron-deficient individuals. Br J Nutr. 2011;105(8):1245-50. doi: 10.1017/S0007114510004903.PubMedUsed to support: Isotope studies in 49 young women showed ferritin strongly predicted absorption from ferrous sulfate but not ferric pyrophosphate; re-analysis of fortification trials in 258 children found low baseline body iron predicted a larger gain with both compounds, significantly more with ferrous sulfate.
  7. Moretti D, Zimmermann MB, Muthayya S, Thankachan P, Lee TC, Kurpad AV, Hurrell RF. Extruded rice fortified with micronized ground ferric pyrophosphate reduces iron deficiency in Indian schoolchildren: a double-blind randomized controlled trial. Am J Clin Nutr. 2006;84(4):822-9. doi: 10.1093/ajcn/84.4.822.PubMedUsed to support: Double-blind randomized 7-month school lunch trial in 184 iron-depleted Indian children: rice fortified with 20 mg iron as micronized ground ferric pyrophosphate raised body iron stores more than unfortified rice and cut iron deficiency (78% to 25% vs 79% to 49% in dewormed groups); the fall in iron-deficiency anemia was not significant. The rice was indistinguishable from natural rice in sensory tests.
  8. Radhika MS, Nair KM, Kumar RH, Rao MV, Ravinder P, Reddy CG, Brahmam GN. Micronized ferric pyrophosphate supplied through extruded rice kernels improves body iron stores in children: a double-blind, randomized, placebo-controlled midday meal feeding trial in Indian schoolchildren. Am J Clin Nutr. 2011;94(5):1202-10. doi: 10.3945/ajcn.110.007179.PubMedUsed to support: Double-blind placebo-controlled 8-month midday-meal trial in 140 Indian schoolchildren: rice with 19 mg iron/day as micronized ferric pyrophosphate raised ferritin by 8.2 mcg/L and cut iron deficiency (33% to 14%), but hemoglobin gains and anemia rates did not differ from unfortified rice.
  9. Zimmermann MB, Wegmueller R, Zeder C, Chaouki N, Rohner F, Saïssi M, Torresani T, Hurrell RF. Dual fortification of salt with iodine and micronized ferric pyrophosphate: a randomized, double-blind, controlled trial. Am J Clin Nutr. 2004;80(4):952-9. doi: 10.1093/ajcn/80.4.952.PubMedUsed to support: Randomized double-blind 10-month trial in 158 Moroccan children: salt dual-fortified with iodine and micronized ferric pyrophosphate (about 18 mg iron/day, about 2% absorbed) raised hemoglobin by 16 g/L and iron stores, and cut iron-deficiency anemia from 30% to 5%; salt color and iodine were stable over 6 months.
  10. Wegmüller R, Camara F, Zimmermann MB, Adou P, Hurrell RF. Salt dual-fortified with iodine and micronized ground ferric pyrophosphate affects iron status but not hemoglobin in children in Cote d'Ivoire. J Nutr. 2006;136(7):1814-20. doi: 10.1093/jn/136.7.1814.PubMedUsed to support: Double-blind 6-month trial in 123 iron-deficient children in Cote d'Ivoire: salt fortified with micronized ground ferric pyrophosphate raised ferritin, transferrin receptor and body iron stores versus iodized salt, but hemoglobin and anemia prevalence did not change; malaria affected 55% of children.
  11. Swiatkowska-Freund M, Sasak-Cieslar N, Szymaniak M, Bednarek S, Pasikowska A, Zorawska H, Szymanska-Boczek M. Assessment of the tolerability and efficacy of supplementation containing micronized and emulsified ferric pyrophosphate in patients with iron deficiency - an observational study. Ginekol Pol. 2026;97(6):437-444. doi: 10.5603/gpl.109970.PubMedUsed to support: Observational study of 119 adults with iron deficiency taking micronized, emulsified ferric pyrophosphate for 3 months: iron rose in 39 of 63 women and ferritin in 38 of 66; 103 of 108 reported lower symptom scores, 41 of those (38%) reported some discomfort, and 83.2% rated the product good or very good. No control group.
  12. Almajali B, Kv G, Kuppusamy G, Zeyaullah M, Teja N, Reddy Karri VVS, Rahamathulla M, Almoyad MAA, Muzammil K, Ahmed MM, Pasha I. Assessment of the safety and efficacy of micronized encapsulated ferric pyrophosphate in patients with iron deficiency anaemia: a phase-IV open-label clinical study. Artif Cells Nanomed Biotechnol. 2026;54(1):150-158. doi: 10.1080/21691401.2026.2618967.PubMedUsed to support: Single-arm, open-label 12-week study in 60 adults aged 18 to 60 with moderate iron-deficiency anemia: micronized encapsulated ferric pyrophosphate taken daily was followed by significant rises in hemoglobin, ferritin and transferrin saturation, with few, mild adverse events and no effect on liver or kidney tests. No control group.
  13. US Food and Drug Administration. 21 CFR 184.1304 Ferric pyrophosphate. Code of Federal Regulations, Title 21. 1988;53 FR 16865, May 12, 1988; 53 FR 20939, June 7, 1988..SourceUsed to support: Not PubMed-indexed (US regulation). Describes ferric pyrophosphate (iron(III) pyrophosphate) as a tan or yellowish white powder and affirms it as generally recognized as safe for use in food as a nutrient supplement, limited only by good manufacturing practice, and allows its use in infant formula.
  14. US Food and Drug Administration. 21 CFR 101.17(e) Dietary supplements containing iron or iron salts. Code of Federal Regulations, Title 21. 2025;21 CFR 101.17(e)..SourceUsed to support: Not PubMed-indexed (US regulation). Requires solid oral dietary supplements containing iron to carry the warning that accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6.
  15. Office of Dietary Supplements, National Institutes of Health. Iron: Fact Sheet for Health Professionals. NIH Office of Dietary Supplements. 2026;Online fact sheet..SourceUsed to support: Not PubMed-indexed (government fact sheet). States the adult Tolerable Upper Intake Level for iron is 45 mg (40 to 45 mg for infants, children and teens), that high-dose iron supplements cause gastrointestinal effects, that iron supplements may interact with levodopa and levothyroxine, that proton pump inhibitors can reduce iron absorption, that experts recommend taking calcium and iron supplements at different times, and that people with hereditary hemochromatosis are at risk of obtaining excess iron.
  16. Roe MA, Collings R, Hoogewerff J, Fairweather-Tait SJ. Relative bioavailability of micronized, dispersible ferric pyrophosphate added to an apple juice drink. Eur J Nutr. 2009;48(2):115-9. doi: 10.1007/s00394-008-0770-3.PubMedUsed to support: Stable-isotope study in 15 women with relatively low iron stores: iron from SunActive Fe (micronized, dispersible ferric pyrophosphate) added to apple juice was absorbed significantly less than ferrous sulfate (5.5% vs 9.1%), a relative bioavailability of 0.6. Absorption from SunActive Fe correlated negatively with serum ferritin (r = -0.76, P = 0.01), as did absorption from ferrous sulfate (r = -0.81), so it rose when iron stores were lower. Funding is not described in the abstract.